Prof. George Hajishengallis

Translating C3 inhibition in periodontal inflammation

University of Pennsylvania, Penn Dental Medicine, Philadelphia, Pennsylvania, USA.

Prof. Disis, Mary L. (Nora)

Vaccines for breast cancer prevention

Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Prof. Carlo La Vecchia

Global epidemiological issues about cancer

Università degli Studi di Milano (“La Statale”), Milano – Italy

Prof. Zoran Gatalica

Breast carcinoma from biomarkers to therapy

Director of Anatomic Pathology, University of Oklahoma Health Sciences Center, Oklahoma, USA. 

Prof. Delia Goletti

COVID-19: translational research studies

National Institute for Infectious Disease L. Spallanzani, Rome, Italy

Prof. Zuo-Feng Zhang

Covid-19 and Noncommunicable diseases Prevention and control

Fielding School of Public Health, University of California, Los Angeles, USA.

Prof. Ettore D. Capoluongo

Current and perspective biomarkers of PAPR-1 inhibitors sensitivity

Faculty of Medicine University Federico II -Naples, Naples, Italy

Prof. Antonio Maria Risitano

Complement therapeutics in hematological disorders: lessons from PNH

AORN Moscati Avellino, Italy and Federico II University of Naples, Naples, Italy

Prof. Jianyu Rao

Molecular Testing and Liquid Biopsy for Ovarian Cancer

UCLA Medical Center, Santa Monica, LA, USA

Prof. Cara Haymaker

Identification of distinct immune signatures in malignant pleural mesothelioma

UT MD Anderson Cancer Center, Houston, TX, US

Prof. Che-Kai Tsao

Age of combination therapy in the treatment of advanced RCC: can we do it better?

Tisch Cancer Institute, Mount Sinai Hospital, NY, USA.

Prof. Antonio Facchiano

Investigating protein- and gene-expression of 27 cytokines/chemokines in melanoma patients. Identification of a 4-genes signature

Istituto Dermopatico dell’Immacolata (IDI-IRCCS), Rome, Italy

Prof. Panagiotis Skendros

Targeting complement: from benchside to bedside | Round Table Discussion

Democritus University of Thrace (DUTH), University Hospital of Alexandroupolis, Greece

Dr Bruna Corradetti

Advanced ovarian cancer: exploiting exosomes to potentiate the anti-cancer immune response

School of Medicine at Swansea University, Wales, UK

Dr Dimitrios C. Mastellos

Complement Immunobiology

National Center for Scientific Research ‘Demokritos’, Athens, Greece

Dr Cristina M. Failla

Immunological checkpoint inhibitors in cutaneous melanoma

Experimental Immunology Laboratory, IDI-IRCCS, Rome, Italy

Dr Tibor Bakács

Severe Herpes Zoster Ophthalmicus: An Autobiographical Case Report

Hungarian Academy of Sciences & HepC Inc, Hungary

Prof. Licia Iacoviello

The common soil hypothesis for Cancer and Cardiovascular disease: evidence from experimental and epidemiological studies

IRCCS Neuromed, Pozzilli & University of Insubria Varese, Italy

Prof. Chulho Oak

Future aspect of smart remote health monitoring in the midst of pandemic such as Covid

Kosin University College of Medicine, Pusan, South Korea

Dr Francesca Scatozza

Expression of autoimmunity-related genes in melanoma samples

Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Rome, Italy

Prof. John B. Liao

Strategies to develop effective immune therapy for ovarian cancer

University of Washington Medical Center, Washington, USA

★ Agenda is being updated regularly